Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Mar;54(3):1173-8.
doi: 10.1128/AAC.01076-09. Epub 2010 Jan 11.

Surveillance and correlation of antibiotic prescription and resistance of Gram-negative bacteria in Singaporean hospitals

Affiliations

Surveillance and correlation of antibiotic prescription and resistance of Gram-negative bacteria in Singaporean hospitals

Li-Yang Hsu et al. Antimicrob Agents Chemother. 2010 Mar.

Abstract

A surveillance study was performed in four Singapore public hospitals from 2006 to 2008 to determine the correlation between antibiotic prescription and Gram-negative bacterial antimicrobial resistance. Targeted organisms included ceftriaxone- and ciprofloxacin-resistant Escherichia coli and Klebsiella pneumoniae, as well as imipenem-resistant Pseudomonas aeruginosa and Acinetobacter spp. Antibiotic prescription data were collated in the WHO anatomical therapeutic chemical (ATC)/defined daily dose (DDD) format, while antibiotic resistance was expressed as incidence density adjusted for total inpatient-days every quarter. Individual trends were determined by linear regression, while possible associations between antibiotic prescription and resistance were evaluated via cross-correlation analysis. Results over 3 years indicated significantly rising incidence densities of ceftriaxone- and ciprofloxacin-resistant E. coli and imipenem-resistant Acinetobacter spp. (blood isolates only). Antimicrobial-resistant Klebsiella pneumoniae rates declined. The prescription rates of piperacillin-tazobactam, ertapenem, meropenem, ciprofloxacin, and levofloxacin increased significantly, while imipenem and moxifloxacin prescription decreased. Cross-correlation analysis demonstrated possible associations between prescription of fluoroquinolones and ciprofloxacin-resistant E. coli (R(2) = 0.46), fluoroquinolones and ceftriaxone-resistant E. coli (R(2) = 0.47), and carbapenems and imipenem-resistant Acinetobacter spp. (R(2) = 0.48), all at zero time lag. Changes in meropenem prescription were associated with a similar trend in imipenem-resistant Acinetobacter blood isolates after a 3-month time lag. No correlation was found between cephalosporin use and resistance. In conclusion, our data demonstrated correlation between prescription of and Gram-negative bacterial resistance to several, but not all, key antimicrobial agents in Singapore hospitals. In areas where Gram-negative bacterial resistance is endemic and prescription of broad-spectrum antimicrobial agents is high, factors other than antimicrobial usage may be equally important in maintaining high resistance rates.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Antibiotic prescription volumes in DDD/1,000 inpatient-days from four public Singapore hospitals over 3 years. (A) Carbapenems. (B) Cephalosporins and piperacillin-tazobactam. (C) Fluoroquinolones.
FIG. 2.
FIG. 2.
Incidence density of antimicrobial-resistant Gram-negative bacteria and respective antibiotic prescription volumes over 3 years. (A) Carbapenem prescription and imipenem-resistant Acinetobacter spp. (B) Cephalosporins and ceftriaxone-resistant E. coli. (C) Fluoroquinolone prescription and ciprofloxacin-resistant E. coli.

Similar articles

Cited by

References

    1. Bartoloni, A., F. Bartalesi, A. Mantella, E. Dell'Amico, M. Roselli, M. Strohmeyer, H. G. Barahona, V. P. Barron, F. Paradisi, and G. M. Rossolini. 2004. High prevalence of acquired antimicrobial resistance unrelated to heavy antimicrobial consumption. J. Infect. Dis. 189:1291-1294. - PubMed
    1. Bergman, M., S. T. Nyberg, P. Huovinen, P. Paakkari, A. J. Hakanen, and the Finnish Study Group for Antimicrobial Resistance. 2009. Association between antimicrobial consumption and resistance in Escherichia coli. Antimicrob. Agents Chemother. 53:913-917. - PubMed
    1. Boucher, H. W., G. H. Talbot, J. S. Bradley, J. E. Edwards, D. Gilbert, L. B. Rice, M. Scheld, B. Spellberg, and J. Bartlett. 2009. Bad bugs need drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin. Infect. Dis. 48:1-12. - PubMed
    1. Clinical and Laboratory Standards Institute. 2005. Performance standards for antimicrobial susceptibility testing. Supplement M100-S14, vol. 24, no. 1. Clinical and Laboratory Standards Institute, Wayne, PA.
    1. Clinical and Laboratory Standards Institute. 2006. Analysis and presentation of cumulative susceptibility test data; approved guideline, 2nd ed. Document M39-A2, vol. 25, no. 28. Clinical and Laboratory Standards Institute, Wayne, PA.

Publication types

MeSH terms

Substances